Antiarrhythmic Therapy for Atrial Fibrillation

Laura V. Tsu, PharmD, BCPS

Disclosures

US Pharmacist. 2013;38(2):20-23. 

In This Article

The Pharmacist's Role

Pharmacists in the community setting are ideally situated to participate in the management of antiarrhythmic therapy in patients with atrial fibrillation. As evidenced by the multitude of interactions, adverse effects, and monitoring parameters listed above, there are many opportunities for pharmacists to provide patient education and to advise prescribers. The initiation or discontinuation of medications that affect concentrations of antiarrhythmic therapy is common, and potentially serious effects could ensue without involvement by the pharmacist. In addition to medication education, the pharmacist also can discuss with patients the indication and purpose of antiarrhythmic medications in the prevention of atrial fibrillation events. In this manner, pharmacists can be involved in the overall management of patients with atrial fibrillation.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....